Global Dihydroartemisinin Market Insights and Forecast to 2031

Report ID: 1230365 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Dihydroartemisinin Product Introduction
    1.2 Market by Type
        1.2.1 Global Dihydroartemisinin Market Size by Type, 2017 VS 2021 VS 2028
        1.2.2 Pharmaceutical Grade
        1.2.3 Industrial Grade
    1.3 Market by Application
        1.3.1 Global Dihydroartemisinin Market Size by Application, 2017 VS 2021 VS 2028
        1.3.2 Malaria Treatment
        1.3.3 Scientific Research
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Dihydroartemisinin Production
    2.1 Global Dihydroartemisinin Production Capacity (2017-2028)
    2.2 Global Dihydroartemisinin Production by Region: 2017 VS 2021 VS 2028
    2.3 Global Dihydroartemisinin Production by Region
        2.3.1 Global Dihydroartemisinin Historic Production by Region (2017-2022)
        2.3.2 Global Dihydroartemisinin Forecasted Production by Region (2023-2028)
    2.4 North America
    2.5 Europe
    2.6 China
    2.7 Japan
3 Global Dihydroartemisinin Sales in Volume & Value Estimates and Forecasts
    3.1 Global Dihydroartemisinin Sales Estimates and Forecasts 2017-2028
    3.2 Global Dihydroartemisinin Revenue Estimates and Forecasts 2017-2028
    3.3 Global Dihydroartemisinin Revenue by Region: 2017 VS 2021 VS 2028
    3.4 Global Dihydroartemisinin Sales by Region
        3.4.1 Global Dihydroartemisinin Sales by Region (2017-2022)
        3.4.2 Global Sales Dihydroartemisinin by Region (2023-2028)
    3.5 Global Dihydroartemisinin Revenue by Region
        3.5.1 Global Dihydroartemisinin Revenue by Region (2017-2022)
        3.5.2 Global Dihydroartemisinin Revenue by Region (2023-2028)
    3.6 North America
    3.7 Europe
    3.8 Asia-Pacific
    3.9 Latin America
    3.10 Middle East & Africa
4 Competition by Manufactures
    4.1 Global Dihydroartemisinin Production Capacity by Manufacturers
    4.2 Global Dihydroartemisinin Sales by Manufacturers
        4.2.1 Global Dihydroartemisinin Sales by Manufacturers (2017-2022)
        4.2.2 Global Dihydroartemisinin Sales Market Share by Manufacturers (2017-2022)
        4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Dihydroartemisinin in 2021
    4.3 Global Dihydroartemisinin Revenue by Manufacturers
        4.3.1 Global Dihydroartemisinin Revenue by Manufacturers (2017-2022)
        4.3.2 Global Dihydroartemisinin Revenue Market Share by Manufacturers (2017-2022)
        4.3.3 Global Top 10 and Top 5 Companies by Dihydroartemisinin Revenue in 2021
    4.4 Global Dihydroartemisinin Sales Price by Manufacturers
    4.5 Analysis of Competitive Landscape
        4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        4.5.2 Global Dihydroartemisinin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        4.5.3 Global Dihydroartemisinin Manufacturers Geographical Distribution
    4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
    5.1 Global Dihydroartemisinin Sales by Type
        5.1.1 Global Dihydroartemisinin Historical Sales by Type (2017-2022)
        5.1.2 Global Dihydroartemisinin Forecasted Sales by Type (2023-2028)
        5.1.3 Global Dihydroartemisinin Sales Market Share by Type (2017-2028)
    5.2 Global Dihydroartemisinin Revenue by Type
        5.2.1 Global Dihydroartemisinin Historical Revenue by Type (2017-2022)
        5.2.2 Global Dihydroartemisinin Forecasted Revenue by Type (2023-2028)
        5.2.3 Global Dihydroartemisinin Revenue Market Share by Type (2017-2028)
    5.3 Global Dihydroartemisinin Price by Type
        5.3.1 Global Dihydroartemisinin Price by Type (2017-2022)
        5.3.2 Global Dihydroartemisinin Price Forecast by Type (2023-2028)
6 Market Size by Application
    6.1 Global Dihydroartemisinin Sales by Application
        6.1.1 Global Dihydroartemisinin Historical Sales by Application (2017-2022)
        6.1.2 Global Dihydroartemisinin Forecasted Sales by Application (2023-2028)
        6.1.3 Global Dihydroartemisinin Sales Market Share by Application (2017-2028)
    6.2 Global Dihydroartemisinin Revenue by Application
        6.2.1 Global Dihydroartemisinin Historical Revenue by Application (2017-2022)
        6.2.2 Global Dihydroartemisinin Forecasted Revenue by Application (2023-2028)
        6.2.3 Global Dihydroartemisinin Revenue Market Share by Application (2017-2028)
    6.3 Global Dihydroartemisinin Price by Application
        6.3.1 Global Dihydroartemisinin Price by Application (2017-2022)
        6.3.2 Global Dihydroartemisinin Price Forecast by Application (2023-2028)
7 North America
    7.1 North America Dihydroartemisinin Market Size by Type
        7.1.1 North America Dihydroartemisinin Sales by Type (2017-2028)
        7.1.2 North America Dihydroartemisinin Revenue by Type (2017-2028)
    7.2 North America Dihydroartemisinin Market Size by Application
        7.2.1 North America Dihydroartemisinin Sales by Application (2017-2028)
        7.2.2 North America Dihydroartemisinin Revenue by Application (2017-2028)
    7.3 North America Dihydroartemisinin Sales by Country
        7.3.1 North America Dihydroartemisinin Sales by Country (2017-2028)
        7.3.2 North America Dihydroartemisinin Revenue by Country (2017-2028)
        7.3.3 U.S.
        7.3.4 Canada
8 Europe
    8.1 Europe Dihydroartemisinin Market Size by Type
        8.1.1 Europe Dihydroartemisinin Sales by Type (2017-2028)
        8.1.2 Europe Dihydroartemisinin Revenue by Type (2017-2028)
    8.2 Europe Dihydroartemisinin Market Size by Application
        8.2.1 Europe Dihydroartemisinin Sales by Application (2017-2028)
        8.2.2 Europe Dihydroartemisinin Revenue by Application (2017-2028)
    8.3 Europe Dihydroartemisinin Sales by Country
        8.3.1 Europe Dihydroartemisinin Sales by Country (2017-2028)
        8.3.2 Europe Dihydroartemisinin Revenue by Country (2017-2028)
        8.3.3 Germany
        8.3.4 France
        8.3.5 U.K.
        8.3.6 Italy
        8.3.7 Russia
9 Asia Pacific
    9.1 Asia Pacific Dihydroartemisinin Market Size by Type
        9.1.1 Asia Pacific Dihydroartemisinin Sales by Type (2017-2028)
        9.1.2 Asia Pacific Dihydroartemisinin Revenue by Type (2017-2028)
    9.2 Asia Pacific Dihydroartemisinin Market Size by Application
        9.2.1 Asia Pacific Dihydroartemisinin Sales by Application (2017-2028)
        9.2.2 Asia Pacific Dihydroartemisinin Revenue by Application (2017-2028)
    9.3 Asia Pacific Dihydroartemisinin Sales by Region
        9.3.1 Asia Pacific Dihydroartemisinin Sales by Region (2017-2028)
        9.3.2 Asia Pacific Dihydroartemisinin Revenue by Region (2017-2028)
        9.3.3 China
        9.3.4 Japan
        9.3.5 South Korea
        9.3.6 India
        9.3.7 Australia
        9.3.8 Taiwan
        9.3.9 Indonesia
        9.3.10 Thailand
        9.3.11 Malaysia
        9.3.12 Philippines
10 Latin America
    10.1 Latin America Dihydroartemisinin Market Size by Type
        10.1.1 Latin America Dihydroartemisinin Sales by Type (2017-2028)
        10.1.2 Latin America Dihydroartemisinin Revenue by Type (2017-2028)
    10.2 Latin America Dihydroartemisinin Market Size by Application
        10.2.1 Latin America Dihydroartemisinin Sales by Application (2017-2028)
        10.2.2 Latin America Dihydroartemisinin Revenue by Application (2017-2028)
    10.3 Latin America Dihydroartemisinin Sales by Country
        10.3.1 Latin America Dihydroartemisinin Sales by Country (2017-2028)
        10.3.2 Latin America Dihydroartemisinin Revenue by Country (2017-2028)
        10.3.3 Mexico
        10.3.4 Brazil
        10.3.5 Argentina
11 Middle East and Africa
    11.1 Middle East and Africa Dihydroartemisinin Market Size by Type
        11.1.1 Middle East and Africa Dihydroartemisinin Sales by Type (2017-2028)
        11.1.2 Middle East and Africa Dihydroartemisinin Revenue by Type (2017-2028)
    11.2 Middle East and Africa Dihydroartemisinin Market Size by Application
        11.2.1 Middle East and Africa Dihydroartemisinin Sales by Application (2017-2028)
        11.2.2 Middle East and Africa Dihydroartemisinin Revenue by Application (2017-2028)
    11.3 Middle East and Africa Dihydroartemisinin Sales by Country
        11.3.1 Middle East and Africa Dihydroartemisinin Sales by Country (2017-2028)
        11.3.2 Middle East and Africa Dihydroartemisinin Revenue by Country (2017-2028)
        11.3.3 Turkey
        11.3.4 Saudi Arabia
        11.3.5 U.A.E
12 Corporate Profiles
    12.1 Sanofi
        12.1.1 Sanofi Corporation Information
        12.1.2 Sanofi Overview
        12.1.3 Sanofi Dihydroartemisinin Sales, Price, Revenue and Gross Margin (2017-2022)
        12.1.4 Sanofi Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications
        12.1.5 Sanofi Recent Developments
    12.2 KPC Pharmaceuticals
        12.2.1 KPC Pharmaceuticals Corporation Information
        12.2.2 KPC Pharmaceuticals Overview
        12.2.3 KPC Pharmaceuticals Dihydroartemisinin Sales, Price, Revenue and Gross Margin (2017-2022)
        12.2.4 KPC Pharmaceuticals Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications
        12.2.5 KPC Pharmaceuticals Recent Developments
    12.3 Guangxi Xiancaotang Pharmaceutical
        12.3.1 Guangxi Xiancaotang Pharmaceutical Corporation Information
        12.3.2 Guangxi Xiancaotang Pharmaceutical Overview
        12.3.3 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales, Price, Revenue and Gross Margin (2017-2022)
        12.3.4 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications
        12.3.5 Guangxi Xiancaotang Pharmaceutical Recent Developments
    12.4 Guilin Pharmaceutical
        12.4.1 Guilin Pharmaceutical Corporation Information
        12.4.2 Guilin Pharmaceutical Overview
        12.4.3 Guilin Pharmaceutical Dihydroartemisinin Sales, Price, Revenue and Gross Margin (2017-2022)
        12.4.4 Guilin Pharmaceutical Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications
        12.4.5 Guilin Pharmaceutical Recent Developments
    12.5 Kerui Nanhai Pharmaceutical
        12.5.1 Kerui Nanhai Pharmaceutical Corporation Information
        12.5.2 Kerui Nanhai Pharmaceutical Overview
        12.5.3 Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales, Price, Revenue and Gross Margin (2017-2022)
        12.5.4 Kerui Nanhai Pharmaceutical Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications
        12.5.5 Kerui Nanhai Pharmaceutical Recent Developments
    12.6 Shanghai Natural Bio-engineering Co
        12.6.1 Shanghai Natural Bio-engineering Co Corporation Information
        12.6.2 Shanghai Natural Bio-engineering Co Overview
        12.6.3 Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales, Price, Revenue and Gross Margin (2017-2022)
        12.6.4 Shanghai Natural Bio-engineering Co Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications
        12.6.5 Shanghai Natural Bio-engineering Co Recent Developments
    12.7 Novanat Bioresource
        12.7.1 Novanat Bioresource Corporation Information
        12.7.2 Novanat Bioresource Overview
        12.7.3 Novanat Bioresource Dihydroartemisinin Sales, Price, Revenue and Gross Margin (2017-2022)
        12.7.4 Novanat Bioresource Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications
        12.7.5 Novanat Bioresource Recent Developments
    12.8 Botanical Extracts EPZ Ltd
        12.8.1 Botanical Extracts EPZ Ltd Corporation Information
        12.8.2 Botanical Extracts EPZ Ltd Overview
        12.8.3 Botanical Extracts EPZ Ltd Dihydroartemisinin Sales, Price, Revenue and Gross Margin (2017-2022)
        12.8.4 Botanical Extracts EPZ Ltd Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications
        12.8.5 Botanical Extracts EPZ Ltd Recent Developments
13 Industry Chain and Sales Channels Analysis
    13.1 Dihydroartemisinin Industry Chain Analysis
    13.2 Dihydroartemisinin Key Raw Materials
        13.2.1 Key Raw Materials
        13.2.2 Raw Materials Key Suppliers
    13.3 Dihydroartemisinin Production Mode & Process
    13.4 Dihydroartemisinin Sales and Marketing
        13.4.1 Dihydroartemisinin Sales Channels
        13.4.2 Dihydroartemisinin Distributors
    13.5 Dihydroartemisinin Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    14.1 Dihydroartemisinin Industry Trends
    14.2 Dihydroartemisinin Market Drivers
    14.3 Dihydroartemisinin Market Challenges
    14.4 Dihydroartemisinin Market Restraints
15 Key Finding in The Global Dihydroartemisinin Study
16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables
    Table 1. Global Dihydroartemisinin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Pharmaceutical Grade
    Table 3. Major Manufacturers of Industrial Grade
    Table 4. Global Dihydroartemisinin Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
    Table 5. Global Dihydroartemisinin Production by Region: 2017 VS 2021 VS 2028 (K MT)
    Table 6. Global Dihydroartemisinin Production by Region (2017-2022) & (K MT)
    Table 7. Global Dihydroartemisinin Production Market Share by Region (2017-2022)
    Table 8. Global Dihydroartemisinin Production by Region (2023-2028) & (K MT)
    Table 9. Global Dihydroartemisinin Production Market Share by Region (2023-2028)
    Table 10. Global Dihydroartemisinin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 11. Global Dihydroartemisinin Sales by Region (2017-2022) & (K MT)
    Table 12. Global Dihydroartemisinin Sales Market Share by Region (2017-2022)
    Table 13. Global Dihydroartemisinin Sales by Region (2023-2028) & (K MT)
    Table 14. Global Dihydroartemisinin Sales Market Share by Region (2023-2028)
    Table 15. Global Dihydroartemisinin Revenue by Region (2017-2022) & (US$ Million)
    Table 16. Global Dihydroartemisinin Revenue Market Share by Region (2017-2022)
    Table 17. Global Dihydroartemisinin Revenue by Region (2023-2028) & (US$ Million)
    Table 18. Global Dihydroartemisinin Revenue Market Share by Region (2023-2028)
    Table 19. Global Dihydroartemisinin Production Capacity by Manufacturers (2017-2022) & (K MT)
    Table 20. Global Dihydroartemisinin Capacity Market Share by Manufacturers (2017-2022)
    Table 21. Global Dihydroartemisinin Sales by Manufacturers (2017-2022) & (K MT)
    Table 22. Global Dihydroartemisinin Sales Market Share by Manufacturers (2017-2022)
    Table 23. Global Dihydroartemisinin Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 24. Global Dihydroartemisinin Revenue Share by Manufacturers (2017-2022)
    Table 25. Dihydroartemisinin Price by Manufacturers 2017-2022 (USD/MT)
    Table 26. Global Dihydroartemisinin Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 27. Global Dihydroartemisinin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dihydroartemisinin as of 2021)
    Table 28. Dihydroartemisinin Manufacturing Base Distribution and Headquarters
    Table 29. Manufacturers Dihydroartemisinin Product Offered
    Table 30. Date of Manufacturers Enter into Dihydroartemisinin Market
    Table 31. Mergers & Acquisitions, Expansion Plans
    Table 32. Global Dihydroartemisinin Sales by Type (2017-2022) & (K MT)
    Table 33. Global Dihydroartemisinin Sales by Type (2023-2028) & (K MT)
    Table 34. Global Dihydroartemisinin Sales Share by Type (2017-2022)
    Table 35. Global Dihydroartemisinin Sales Share by Type (2023-2028)
    Table 36. Global Dihydroartemisinin Revenue by Type (2017-2022) & (US$ Million)
    Table 37. Global Dihydroartemisinin Revenue by Type (2023-2028) & (US$ Million)
    Table 38. Global Dihydroartemisinin Revenue Share by Type (2017-2022)
    Table 39. Global Dihydroartemisinin Revenue Share by Type (2023-2028)
    Table 40. Dihydroartemisinin Price by Type (2017-2022) & (USD/MT)
    Table 41. Global Dihydroartemisinin Price Forecast by Type (2023-2028) & (USD/MT)
    Table 42. Global Dihydroartemisinin Sales by Application (2017-2022) & (K MT)
    Table 43. Global Dihydroartemisinin Sales by Application (2023-2028) & (K MT)
    Table 44. Global Dihydroartemisinin Sales Share by Application (2017-2022)
    Table 45. Global Dihydroartemisinin Sales Share by Application (2023-2028)
    Table 46. Global Dihydroartemisinin Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Dihydroartemisinin Revenue by Application (2023-2028) & (US$ Million)
    Table 48. Global Dihydroartemisinin Revenue Share by Application (2017-2022)
    Table 49. Global Dihydroartemisinin Revenue Share by Application (2023-2028)
    Table 50. Dihydroartemisinin Price by Application (2017-2022) & (USD/MT)
    Table 51. Global Dihydroartemisinin Price Forecast by Application (2023-2028) & (USD/MT)
    Table 52. North America Dihydroartemisinin Sales by Type (2017-2022) & (K MT)
    Table 53. North America Dihydroartemisinin Sales by Type (2023-2028) & (K MT)
    Table 54. North America Dihydroartemisinin Revenue by Type (2017-2022) & (US$ Million)
    Table 55. North America Dihydroartemisinin Revenue by Type (2023-2028) & (US$ Million)
    Table 56. North America Dihydroartemisinin Sales by Application (2017-2022) & (K MT)
    Table 57. North America Dihydroartemisinin Sales by Application (2023-2028) & (K MT)
    Table 58. North America Dihydroartemisinin Revenue by Application (2017-2022) & (US$ Million)
    Table 59. North America Dihydroartemisinin Revenue by Application (2023-2028) & (US$ Million)
    Table 60. North America Dihydroartemisinin Sales by Country (2017-2022) & (K MT)
    Table 61. North America Dihydroartemisinin Sales by Country (2023-2028) & (K MT)
    Table 62. North America Dihydroartemisinin Revenue by Country (2017-2022) & (US$ Million)
    Table 63. North America Dihydroartemisinin Revenue by Country (2023-2028) & (US$ Million)
    Table 64. Europe Dihydroartemisinin Sales by Type (2017-2022) & (K MT)
    Table 65. Europe Dihydroartemisinin Sales by Type (2023-2028) & (K MT)
    Table 66. Europe Dihydroartemisinin Revenue by Type (2017-2022) & (US$ Million)
    Table 67. Europe Dihydroartemisinin Revenue by Type (2023-2028) & (US$ Million)
    Table 68. Europe Dihydroartemisinin Sales by Application (2017-2022) & (K MT)
    Table 69. Europe Dihydroartemisinin Sales by Application (2023-2028) & (K MT)
    Table 70. Europe Dihydroartemisinin Revenue by Application (2017-2022) & (US$ Million)
    Table 71. Europe Dihydroartemisinin Revenue by Application (2023-2028) & (US$ Million)
    Table 72. Europe Dihydroartemisinin Sales by Country (2017-2022) & (K MT)
    Table 73. Europe Dihydroartemisinin Sales by Country (2023-2028) & (K MT)
    Table 74. Europe Dihydroartemisinin Revenue by Country (2017-2022) & (US$ Million)
    Table 75. Europe Dihydroartemisinin Revenue by Country (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Dihydroartemisinin Sales by Type (2017-2022) & (K MT)
    Table 77. Asia Pacific Dihydroartemisinin Sales by Type (2023-2028) & (K MT)
    Table 78. Asia Pacific Dihydroartemisinin Revenue by Type (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Dihydroartemisinin Revenue by Type (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Dihydroartemisinin Sales by Application (2017-2022) & (K MT)
    Table 81. Asia Pacific Dihydroartemisinin Sales by Application (2023-2028) & (K MT)
    Table 82. Asia Pacific Dihydroartemisinin Revenue by Application (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Dihydroartemisinin Revenue by Application (2023-2028) & (US$ Million)
    Table 84. Asia Pacific Dihydroartemisinin Sales by Region (2017-2022) & (K MT)
    Table 85. Asia Pacific Dihydroartemisinin Sales by Region (2023-2028) & (K MT)
    Table 86. Asia Pacific Dihydroartemisinin Revenue by Region (2017-2022) & (US$ Million)
    Table 87. Asia Pacific Dihydroartemisinin Revenue by Region (2023-2028) & (US$ Million)
    Table 88. Latin America Dihydroartemisinin Sales by Type (2017-2022) & (K MT)
    Table 89. Latin America Dihydroartemisinin Sales by Type (2023-2028) & (K MT)
    Table 90. Latin America Dihydroartemisinin Revenue by Type (2017-2022) & (US$ Million)
    Table 91. Latin America Dihydroartemisinin Revenue by Type (2023-2028) & (US$ Million)
    Table 92. Latin America Dihydroartemisinin Sales by Application (2017-2022) & (K MT)
    Table 93. Latin America Dihydroartemisinin Sales by Application (2023-2028) & (K MT)
    Table 94. Latin America Dihydroartemisinin Revenue by Application (2017-2022) & (US$ Million)
    Table 95. Latin America Dihydroartemisinin Revenue by Application (2023-2028) & (US$ Million)
    Table 96. Latin America Dihydroartemisinin Sales by Country (2017-2022) & (K MT)
    Table 97. Latin America Dihydroartemisinin Sales by Country (2023-2028) & (K MT)
    Table 98. Latin America Dihydroartemisinin Revenue by Country (2017-2022) & (US$ Million)
    Table 99. Latin America Dihydroartemisinin Revenue by Country (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Dihydroartemisinin Sales by Type (2017-2022) & (K MT)
    Table 101. Middle East and Africa Dihydroartemisinin Sales by Type (2023-2028) & (K MT)
    Table 102. Middle East and Africa Dihydroartemisinin Revenue by Type (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Dihydroartemisinin Revenue by Type (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Dihydroartemisinin Sales by Application (2017-2022) & (K MT)
    Table 105. Middle East and Africa Dihydroartemisinin Sales by Application (2023-2028) & (K MT)
    Table 106. Middle East and Africa Dihydroartemisinin Revenue by Application (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Dihydroartemisinin Revenue by Application (2023-2028) & (US$ Million)
    Table 108. Middle East and Africa Dihydroartemisinin Sales by Country (2017-2022) & (K MT)
    Table 109. Middle East and Africa Dihydroartemisinin Sales by Country (2023-2028) & (K MT)
    Table 110. Middle East and Africa Dihydroartemisinin Revenue by Country (2017-2022) & (US$ Million)
    Table 111. Middle East and Africa Dihydroartemisinin Revenue by Country (2023-2028) & (US$ Million)
    Table 112. Sanofi Corporation Information
    Table 113. Sanofi Description and Major Businesses
    Table 114. Sanofi Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 115. Sanofi Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Sanofi Recent Development
    Table 117. KPC Pharmaceuticals Corporation Information
    Table 118. KPC Pharmaceuticals Description and Major Businesses
    Table 119. KPC Pharmaceuticals Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 120. KPC Pharmaceuticals Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. KPC Pharmaceuticals Recent Development
    Table 122. Guangxi Xiancaotang Pharmaceutical Corporation Information
    Table 123. Guangxi Xiancaotang Pharmaceutical Description and Major Businesses
    Table 124. Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 125. Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Guangxi Xiancaotang Pharmaceutical Recent Development
    Table 127. Guilin Pharmaceutical Corporation Information
    Table 128. Guilin Pharmaceutical Description and Major Businesses
    Table 129. Guilin Pharmaceutical Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 130. Guilin Pharmaceutical Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Guilin Pharmaceutical Recent Development
    Table 132. Kerui Nanhai Pharmaceutical Corporation Information
    Table 133. Kerui Nanhai Pharmaceutical Description and Major Businesses
    Table 134. Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 135. Kerui Nanhai Pharmaceutical Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Kerui Nanhai Pharmaceutical Recent Development
    Table 137. Shanghai Natural Bio-engineering Co Corporation Information
    Table 138. Shanghai Natural Bio-engineering Co Description and Major Businesses
    Table 139. Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 140. Shanghai Natural Bio-engineering Co Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Shanghai Natural Bio-engineering Co Recent Development
    Table 142. Novanat Bioresource Corporation Information
    Table 143. Novanat Bioresource Description and Major Businesses
    Table 144. Novanat Bioresource Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 145. Novanat Bioresource Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Novanat Bioresource Recent Development
    Table 147. Botanical Extracts EPZ Ltd Corporation Information
    Table 148. Botanical Extracts EPZ Ltd Description and Major Businesses
    Table 149. Botanical Extracts EPZ Ltd Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 150. Botanical Extracts EPZ Ltd Dihydroartemisinin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Botanical Extracts EPZ Ltd Recent Development
    Table 152. Key Raw Materials Lists
    Table 153. Raw Materials Key Suppliers Lists
    Table 154. Dihydroartemisinin Distributors List
    Table 155. Dihydroartemisinin Customers List
    Table 156. Dihydroartemisinin Market Trends
    Table 157. Dihydroartemisinin Market Drivers
    Table 158. Dihydroartemisinin Market Challenges
    Table 159. Dihydroartemisinin Market Restraints
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dihydroartemisinin Product Picture
    Figure 2. Global Dihydroartemisinin Market Share by Type in 2021 & 2028
    Figure 3. Pharmaceutical Grade Product Picture
    Figure 4. Industrial Grade Product Picture
    Figure 5. Global Dihydroartemisinin Market Share by Application in 2021 & 2028
    Figure 6. Malaria Treatment
    Figure 7. Scientific Research
    Figure 8. Others
    Figure 9. Dihydroartemisinin Report Years Considered
    Figure 10. Global Dihydroartemisinin Capacity, Production and Utilization (2017-2028) & (K MT)
    Figure 11. Global Dihydroartemisinin Production Market Share by Region in Percentage: 2021 Versus 2028
    Figure 12. Global Dihydroartemisinin Production Market Share by Region (2017-2022)
    Figure 13. Global Dihydroartemisinin Production Market Share by Region (2023-2028)
    Figure 14. Dihydroartemisinin Production Growth Rate in North America (2017-2028) & (K MT)
    Figure 15. Dihydroartemisinin Production Growth Rate in Europe (2017-2028) & (K MT)
    Figure 16. Dihydroartemisinin Production Growth Rate in China (2017-2028) & (K MT)
    Figure 17. Dihydroartemisinin Production Growth Rate in Japan (2017-2028) & (K MT)
    Figure 18. Global Dihydroartemisinin Sales 2017-2028 (K MT)
    Figure 19. Global Dihydroartemisinin Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 20. Global Dihydroartemisinin Revenue 2017-2028 (US$ Million)
    Figure 21. Global Dihydroartemisinin Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 22. Global Dihydroartemisinin Sales Market Share by Region (2017-2022)
    Figure 23. Global Dihydroartemisinin Sales Market Share by Region (2023-2028)
    Figure 24. North America Dihydroartemisinin Sales YoY (2017-2028) & (K MT)
    Figure 25. North America Dihydroartemisinin Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Europe Dihydroartemisinin Sales YoY (2017-2028) & (K MT)
    Figure 27. Europe Dihydroartemisinin Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Dihydroartemisinin Sales YoY (2017-2028) & (K MT)
    Figure 29. Asia-Pacific Dihydroartemisinin Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. Latin America Dihydroartemisinin Sales YoY (2017-2028) & (K MT)
    Figure 31. Latin America Dihydroartemisinin Revenue YoY (2017-2028) & (US$ Million)
    Figure 32. Middle East & Africa Dihydroartemisinin Sales YoY (2017-2028) & (K MT)
    Figure 33. Middle East & Africa Dihydroartemisinin Revenue YoY (2017-2028) & (US$ Million)
    Figure 34. The Dihydroartemisinin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 35. The Top 5 and 10 Largest Manufacturers of Dihydroartemisinin in the World: Market Share by Dihydroartemisinin Revenue in 2021
    Figure 36. Dihydroartemisinin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 37. Global Dihydroartemisinin Sales Market Share by Type (2017-2028)
    Figure 38. Global Dihydroartemisinin Revenue Market Share by Type (2017-2028)
    Figure 39. Global Dihydroartemisinin Sales Market Share by Application (2017-2028)
    Figure 40. Global Dihydroartemisinin Revenue Market Share by Application (2017-2028)
    Figure 41. North America Dihydroartemisinin Sales Market Share by Type (2017-2028)
    Figure 42. North America Dihydroartemisinin Revenue Market Share by Type (2017-2028)
    Figure 43. North America Dihydroartemisinin Sales Market Share by Application (2017-2028)
    Figure 44. North America Dihydroartemisinin Revenue Market Share by Application (2017-2028)
    Figure 45. North America Dihydroartemisinin Sales Share by Country (2017-2028)
    Figure 46. North America Dihydroartemisinin Revenue Share by Country (2017-2028)
    Figure 47. U.S. Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 48. Canada Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 49. Europe Dihydroartemisinin Sales Market Share by Type (2017-2028)
    Figure 50. Europe Dihydroartemisinin Revenue Market Share by Type (2017-2028)
    Figure 51. Europe Dihydroartemisinin Sales Market Share by Application (2017-2028)
    Figure 52. Europe Dihydroartemisinin Revenue Market Share by Application (2017-2028)
    Figure 53. Europe Dihydroartemisinin Sales Share by Country (2017-2028)
    Figure 54. Europe Dihydroartemisinin Revenue Share by Country (2017-2028)
    Figure 55. Germany Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 56. France Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 57. U.K. Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 58. Italy Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 59. Russia Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 60. Asia Pacific Dihydroartemisinin Sales Market Share by Type (2017-2028)
    Figure 61. Asia Pacific Dihydroartemisinin Revenue Market Share by Type (2017-2028)
    Figure 62. Asia Pacific Dihydroartemisinin Sales Market Share by Application (2017-2028)
    Figure 63. Asia Pacific Dihydroartemisinin Revenue Market Share by Application (2017-2028)
    Figure 64. Asia Pacific Dihydroartemisinin Sales Share by Region (2017-2028)
    Figure 65. Asia Pacific Dihydroartemisinin Revenue Share by Region (2017-2028)
    Figure 66. China Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 67. Japan Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 68. South Korea Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 69. India Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 70. Australia Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 71. Taiwan Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 72. Indonesia Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 73. Thailand Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 74. Malaysia Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 75. Philippines Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 76. Latin America Dihydroartemisinin Sales Market Share by Type (2017-2028)
    Figure 77. Latin America Dihydroartemisinin Revenue Market Share by Type (2017-2028)
    Figure 78. Latin America Dihydroartemisinin Sales Market Share by Application (2017-2028)
    Figure 79. Latin America Dihydroartemisinin Revenue Market Share by Application (2017-2028)
    Figure 80. Latin America Dihydroartemisinin Sales Share by Country (2017-2028)
    Figure 81. Latin America Dihydroartemisinin Revenue Share by Country (2017-2028)
    Figure 82. Mexico Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 83. Brazil Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 84. Argentina Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 85. Middle East and Africa Dihydroartemisinin Sales Market Share by Type (2017-2028)
    Figure 86. Middle East and Africa Dihydroartemisinin Revenue Market Share by Type (2017-2028)
    Figure 87. Middle East and Africa Dihydroartemisinin Sales Market Share by Application (2017-2028)
    Figure 88. Middle East and Africa Dihydroartemisinin Revenue Market Share by Application (2017-2028)
    Figure 89. Middle East and Africa Dihydroartemisinin Sales Share by Country (2017-2028)
    Figure 90. Middle East and Africa Dihydroartemisinin Revenue Share by Country (2017-2028)
    Figure 91. Turkey Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 92. Saudi Arabia Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 93. U.A.E Dihydroartemisinin Revenue (2017-2028) & (US$ Million)
    Figure 94. Dihydroartemisinin Value Chain
    Figure 95. Dihydroartemisinin Production Process
    Figure 96. Channels of Distribution
    Figure 97. Distributors Profiles
    Figure 98. Bottom-up and Top-down Approaches for This Report
    Figure 99. Data Triangulation
    Figure 100. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
KPC Pharmaceuticals
Guangxi Xiancaotang Pharmaceutical
Guilin Pharmaceutical
Kerui Nanhai Pharmaceutical
Shanghai Natural Bio-engineering Co
Novanat Bioresource
Botanical Extracts EPZ Ltd
Frequently Asked Questions
Dihydroartemisinin report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Dihydroartemisinin report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Dihydroartemisinin report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Breathable Textile

Breathable Textile market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More